 Michael Mesches
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 7 | 2025 | 1857 | 0.330 |
Why?
| | Hippocampus | 8 | 2025 | 929 | 0.310 |
Why?
| | Memory Disorders | 3 | 2008 | 177 | 0.310 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2007 | 218 | 0.250 |
Why?
| | Sulindac | 1 | 2004 | 16 | 0.220 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 155 | 0.210 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2024 | 47 | 0.210 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2004 | 100 | 0.200 |
Why?
| | Glycine | 1 | 2024 | 174 | 0.200 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2023 | 38 | 0.200 |
Why?
| | Encephalitis | 1 | 2004 | 136 | 0.190 |
Why?
| | Fear | 3 | 2008 | 344 | 0.180 |
Why?
| | NF-kappa B | 1 | 2025 | 678 | 0.170 |
Why?
| | Long-Term Potentiation | 2 | 2002 | 199 | 0.170 |
Why?
| | Amygdala | 3 | 1996 | 191 | 0.170 |
Why?
| | Ethanol | 1 | 2025 | 615 | 0.170 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4316 | 0.160 |
Why?
| | Memory | 3 | 2007 | 258 | 0.160 |
Why?
| | Nanoparticles | 1 | 2025 | 469 | 0.150 |
Why?
| | Epilepsy | 1 | 2023 | 335 | 0.150 |
Why?
| | Seizures | 3 | 2023 | 431 | 0.150 |
Why?
| | Maze Learning | 5 | 2008 | 103 | 0.150 |
Why?
| | Rats | 14 | 2008 | 5591 | 0.140 |
Why?
| | 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1996 | 6 | 0.130 |
Why?
| | Mice, Inbred C57BL | 2 | 2025 | 5801 | 0.130 |
Why?
| | Escape Reaction | 1 | 1996 | 58 | 0.130 |
Why?
| | Rats, Inbred F344 | 7 | 2004 | 267 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3143 | 0.120 |
Why?
| | Taste | 1 | 1996 | 230 | 0.110 |
Why?
| | Animals | 17 | 2025 | 37243 | 0.090 |
Why?
| | Stress, Psychological | 1 | 1999 | 1124 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 6 | 2007 | 2497 | 0.070 |
Why?
| | Animals, Newborn | 3 | 2024 | 859 | 0.070 |
Why?
| | Space Perception | 1 | 2008 | 81 | 0.070 |
Why?
| | Memory, Short-Term | 1 | 2008 | 257 | 0.060 |
Why?
| | Synapses | 2 | 2007 | 426 | 0.060 |
Why?
| | Glutamic Acid | 1 | 2007 | 255 | 0.060 |
Why?
| | Calcium Channel Blockers | 2 | 2003 | 172 | 0.060 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 1 | 2004 | 23 | 0.050 |
Why?
| | Nootropic Agents | 1 | 2004 | 29 | 0.050 |
Why?
| | Thiazolidinediones | 1 | 2004 | 138 | 0.050 |
Why?
| | Inflammasomes | 1 | 2025 | 133 | 0.050 |
Why?
| | Nimodipine | 1 | 2003 | 6 | 0.050 |
Why?
| | Hydrocephalus | 1 | 2024 | 108 | 0.050 |
Why?
| | Nerve Growth Factor | 1 | 2003 | 34 | 0.050 |
Why?
| | Neuroprotective Agents | 1 | 2004 | 138 | 0.050 |
Why?
| | Mice | 3 | 2025 | 17828 | 0.050 |
Why?
| | Microglia | 1 | 2025 | 256 | 0.050 |
Why?
| | Kynurenic Acid | 1 | 2002 | 20 | 0.050 |
Why?
| | Neural Inhibition | 2 | 2002 | 177 | 0.050 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2002 | 69 | 0.050 |
Why?
| | Calcium Channels, L-Type | 1 | 2003 | 117 | 0.050 |
Why?
| | Motor Skills | 1 | 2002 | 100 | 0.040 |
Why?
| | Down-Regulation | 1 | 2004 | 636 | 0.040 |
Why?
| | Brain | 2 | 2024 | 2791 | 0.040 |
Why?
| | Synaptic Transmission | 2 | 2003 | 295 | 0.040 |
Why?
| | Male | 13 | 2024 | 68250 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 358 | 0.040 |
Why?
| | Up-Regulation | 1 | 2004 | 852 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 310 | 0.040 |
Why?
| | Norepinephrine | 2 | 2002 | 192 | 0.040 |
Why?
| | Cerebellum | 1 | 2002 | 218 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 966 | 0.040 |
Why?
| | Action Potentials | 2 | 2002 | 485 | 0.040 |
Why?
| | Oxidants | 1 | 1999 | 112 | 0.040 |
Why?
| | Cats | 1 | 1999 | 224 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2003 | 511 | 0.040 |
Why?
| | Antioxidants | 1 | 2002 | 593 | 0.040 |
Why?
| | Learning | 1 | 2002 | 422 | 0.040 |
Why?
| | Corticosterone | 1 | 1999 | 242 | 0.040 |
Why?
| | Kainic Acid | 2 | 2008 | 34 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2002 | 559 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 1999 | 332 | 0.030 |
Why?
| | Adenosine | 1 | 1999 | 241 | 0.030 |
Why?
| | Neurons | 2 | 2023 | 1602 | 0.030 |
Why?
| | Electroshock | 1 | 1996 | 143 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2023 | 3029 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 1996 | 191 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1179 | 0.030 |
Why?
| | Electrophysiology | 2 | 2007 | 217 | 0.030 |
Why?
| | Cytokines | 1 | 2002 | 2083 | 0.030 |
Why?
| | Bicuculline | 1 | 1993 | 22 | 0.030 |
Why?
| | Amnesia | 1 | 1993 | 46 | 0.030 |
Why?
| | Stress, Physiological | 1 | 1996 | 450 | 0.020 |
Why?
| | Midazolam | 1 | 1993 | 69 | 0.020 |
Why?
| | Mutation | 1 | 2024 | 3984 | 0.020 |
Why?
| | Blotting, Western | 2 | 2007 | 1232 | 0.020 |
Why?
| | Benzodiazepines | 1 | 1993 | 154 | 0.020 |
Why?
| | Female | 4 | 2025 | 74016 | 0.020 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2002 | 124 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2004 | 10921 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2008 | 91 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2008 | 107 | 0.020 |
Why?
| | Catheterization | 2 | 2002 | 182 | 0.020 |
Why?
| | Mossy Fibers, Hippocampal | 1 | 2007 | 12 | 0.020 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2007 | 19 | 0.020 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2007 | 41 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2007 | 78 | 0.020 |
Why?
| | Cross-Linking Reagents | 1 | 2007 | 215 | 0.020 |
Why?
| | Dendrites | 1 | 2007 | 103 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1317 | 0.010 |
Why?
| | Mental Recall | 1 | 2007 | 207 | 0.010 |
Why?
| | Behavior, Animal | 2 | 2002 | 512 | 0.010 |
Why?
| | Pregnancy | 2 | 2008 | 6870 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 2007 | 302 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 464 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2008 | 1057 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1730 | 0.010 |
Why?
| | Spirulina | 1 | 2002 | 4 | 0.010 |
Why?
| | Cucumis sativus | 1 | 2002 | 5 | 0.010 |
Why?
| | Spatial Behavior | 1 | 2002 | 26 | 0.010 |
Why?
| | Iontophoresis | 1 | 2002 | 13 | 0.010 |
Why?
| | Malus | 1 | 2002 | 11 | 0.010 |
Why?
| | Malondialdehyde | 1 | 2002 | 29 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2003 | 174 | 0.010 |
Why?
| | Spermine | 1 | 2002 | 27 | 0.010 |
Why?
| | Microinjections | 1 | 2002 | 86 | 0.010 |
Why?
| | Calcium Channels | 1 | 2003 | 156 | 0.010 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2002 | 104 | 0.010 |
Why?
| | Phytotherapy | 1 | 2002 | 85 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2002 | 110 | 0.010 |
Why?
| | Purkinje Cells | 1 | 2002 | 68 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2002 | 276 | 0.010 |
Why?
| | Reaction Time | 1 | 2003 | 421 | 0.010 |
Why?
| | Anxiety | 1 | 2008 | 1070 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2002 | 196 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2007 | 1149 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2003 | 185 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 396 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1090 | 0.010 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 1999 | 17 | 0.010 |
Why?
| | Xanthines | 1 | 1999 | 23 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1999 | 24 | 0.010 |
Why?
| | Theophylline | 1 | 1999 | 42 | 0.010 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1999 | 76 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 1999 | 157 | 0.010 |
Why?
| | Gene Expression | 1 | 2002 | 1487 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2002 | 898 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2002 | 2815 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 1993 | 114 | 0.010 |
Why?
| | Neural Conduction | 1 | 1993 | 89 | 0.010 |
Why?
| | Avoidance Learning | 1 | 1993 | 74 | 0.010 |
Why?
| | Receptors, GABA-A | 1 | 1993 | 141 | 0.010 |
Why?
| | Inflammation | 1 | 2002 | 2853 | 0.010 |
Why?
|
|
Mesches's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|